Amani Harris, SMIGS The Sutherland Hospital
Samar Nahas, University of California Riverside
![Sven Becker](http://assets.swoogo.com/uploads/thumb/3100232-6539e9a620be7.jpg)
![Amani Harris](http://assets.swoogo.com/uploads/thumb/3100279-6539ed2f02eb6.png)
![Samar Nahas](http://assets.swoogo.com/uploads/thumb/3070092-65304e5b4cfc9.png)
During this Rapid-Fire Overview, three controversial topics will be addressed: Morcellation and its oncologic implications with regard to sarcoma. True risks will be assessed and the difficult issue of its impact on our surgical practice will be put into perspective. There is new and highly interesting data about the benefits of prophylactic salpingectomy, including opportunistic salpingectomy, which could hugely influence our daily practice and might even affect our collaboration with other specialties. Finally, amid a renaissance of Hormone Replacement Therapy, the available data with regard to risks and benefits will be reviewed and future prospects discussed.
Learning Objectives: At the conclusion of this course, the participant will: 1) Cite the statistics about oncologic risks with regard to morcellation, salpingectomy and hormone replacement therapy; 2) Quote the current literature with regard to ovarian cancer risk and risk reduction; and 3) Describe the changing assessment of the risks and benefits of hormone replacement therapy.
Course Outline
11:30 am Welcome, Introduction, and Course Overview
Sven Becker
11:35 am Morcellation – revisited
Samar Nahas
11:45 am Prophylactic Salpingectomy – Are We Doing the Right Thing?
Amani Harris
12:00 pm Hormone Replacement Therapy – Where Are We Going?
Sven Becker
12:20 pm Questions and Answers
All Faculty
12:30 pm Adjourn
201 Rep. John Lewis Way S
Nashville, TN 37203
United States